Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 2.7M | 3.6M | 3.1M | 2.6M | 2.3M | -- |
| General And Administrative Expense | 2.7M | 3.6M | 3.1M | 2.6M | 2.3M | -- |
| Research And Development | 2.2M | 3.3M | 2.4M | -457,000 | 4.7M | -- |
| Depreciation And Amortization In Income Statement | 12,000 | 4,000 | 3,000 | 4,000 | 4,000 | -- |
| Operating Expense | 4.9M | 6.9M | 5.5M | 2.2M | 7.0M | -- |
| Operating Income | -4.9M | -6.9M | -5.5M | -2.2M | -7.0M | -- |
| EBIT | -4.9M | -6.9M | -5.5M | -1.2M | -7.0M | -- |
| Interest Expense | -- | -- | 84,000 | -- | -- | -- |
| Interest Expense Non Operating | -- | -- | 84,000 | -- | -- | -- |
| Interest Income | -- | -- | -- | 131,000 | 12,000 | 93,000 |
| Interest Income Non Operating | -- | -- | -- | 131,000 | 12,000 | 93,000 |
| Net Interest Income | -212,000 | -110,000 | -84,000 | -76,000 | 12,000 | -- |
| Other Income Expense | 2,000 | -12,000 | 2,000 | 678,000 | -- | -- |
| Gain On Sale Of Security | 2,000 | -12,000 | 2,000 | 678,000 | -- | -- |
| Pretax Income | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Income From Continuing Operation Net Minority Interest | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Income Including Noncontrolling Interests | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Income Common Stockholders | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Income | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| EBITDA | -4.8M | -6.8M | -5.4M | -1.1M | -6.9M | -- |
| Normalized EBITDA | -4.8M | -6.8M | -5.4M | -1.7M | -6.9M | -- |
| Reconciled Depreciation | 111,000 | 102,000 | 99,000 | 97,000 | 96,000 | -- |
| Basic EPS | -2.01 | -2.76 | -2.61 | -- | -11.33 | -12.99 |
| Diluted EPS | -2.01 | -2.76 | -2.61 | -- | -11.33 | -12.99 |
| Basic Average Shares | 2.6M | 2.6M | 2.1M | -- | 613,604 | 558,476 |
| Diluted Average Shares | 2.6M | 2.6M | 2.1M | -- | 613,604 | 558,476 |
| Total Unusual Items | 2,000 | -12,000 | 2,000 | 678,000 | -- | -- |
| Total Unusual Items Excluding Goodwill | 2,000 | -12,000 | 2,000 | 678,000 | -- | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -5.1M | -7.0M | -5.5M | -2.3M | -7.0M | -- |
| Depreciation Amortization Depletion Income Statement | 12,000 | 4,000 | 3,000 | 4,000 | 4,000 | -- |
| Depreciation Income Statement | 12,000 | 4,000 | 3,000 | 4,000 | 4,000 | -- |
| Diluted NI Availto Com Stockholders | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Income Continuous Operations | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Non Operating Interest Income Expense | -212,000 | -110,000 | -84,000 | -76,000 | 12,000 | -- |
| Other Gand A | 2.7M | 3.6M | 2.9M | 2.6M | 2.2M | -- |
| Salaries And Wages | 14,000 | 51,000 | 186,000 | 28,000 | 68,000 | -- |
| Total Expenses | 4.9M | 6.9M | 5.5M | 2.2M | 7.0M | -- |
| Total Other Finance Cost | 212,000 | 110,000 | -- | -- | -12,000 | -93,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 613,000 | 553,000 | 4.7M | 6.2M | -- | 8.3M |
| Cash Cash Equivalents And Short Term Investments | 613,000 | 553,000 | 4.7M | 6.2M | -- | 8.3M |
| Cash Equivalents | -- | -- | 3.4M | 4.6M | -- | 5.0M |
| Cash Financial | -- | 553,000 | 1.3M | 1.5M | -- | 3.3M |
| Prepaid Assets | 2.0M | 1.9M | 2.0M | 2.3M | 912,000 | -- |
| Other Current Assets | 127,000 | 116,000 | 317,000 | 570,000 | 1.4M | -- |
| Current Assets | 3.8M | 3.3M | 7.0M | 9.5M | 10.2M | -- |
| Gross PPE | 3.1M | 3.1M | 3.1M | 3.7M | 3.2M | -- |
| Accumulated Depreciation | -2.8M | -2.7M | -2.6M | -3.1M | -2.5M | -- |
| Net PPE | 285,000 | 396,000 | 498,000 | 597,000 | 694,000 | -- |
| Other Non Current Assets | 2.3M | 1.9M | -- | -- | -- | -- |
| Total Non Current Assets | 2.6M | 2.3M | 498,000 | 597,000 | 694,000 | -- |
| Total Assets | 6.3M | 5.6M | 7.5M | 10.1M | 10.9M | -- |
| Current Debt And Capital Lease Obligation | 305,000 | 413,000 | 441,000 | 428,000 | 416,000 | -- |
| Accounts Payable | 1.5M | 2.9M | 2.4M | 1.3M | 1.8M | -- |
| Payables | 1.5M | 2.9M | 2.4M | 1.3M | 1.8M | -- |
| Payables And Accrued Expenses | 6.8M | 8.6M | 5.9M | 4.0M | 9.3M | -- |
| Current Accrued Expenses | 5.3M | 5.7M | 3.5M | 2.8M | 7.5M | -- |
| Current Liabilities | 7.1M | 9.0M | 6.3M | 4.5M | 9.8M | -- |
| Long Term Debt | 18.7M | 11.0M | 8.5M | 10.0M | 10.0M | -- |
| Long Term Debt And Capital Lease Obligation | 18.7M | 11.0M | 8.5M | 10.2M | 10.3M | -- |
| Long Term Capital Lease Obligation | 0.00 | 0.00 | 80,000 | 193,000 | 305,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 18.7M | 11.0M | 8.5M | 10.2M | 10.3M | -- |
| Total Liabilities Net Minority Interest | 25.8M | 20.0M | 14.9M | 14.7M | 20.1M | -- |
| Common Stock | 459.8M | 459.8M | 459.8M | 457.4M | 452.3M | -- |
| Capital Stock | 459.8M | 459.8M | 459.8M | 457.4M | 452.3M | -- |
| Additional Paid In Capital | 83.8M | 83.7M | 83.7M | 83.3M | 82.3M | -- |
| Retained Earnings | -558.7M | -553.6M | -546.5M | -541.0M | -539.4M | -- |
| Gains Losses Not Affecting Retained Earnings | -4.3M | -4.3M | -4.3M | -4.3M | -4.3M | -- |
| Other Equity Adjustments | -4.3M | -4.3M | -4.3M | -4.3M | -4.3M | -- |
| Common Stock Equity | -19.4M | -14.4M | -7.4M | -4.5M | -9.1M | -- |
| Stockholders Equity | -19.4M | -14.4M | -7.4M | -4.5M | -9.1M | -- |
| Total Equity Gross Minority Interest | -19.4M | -14.4M | -7.4M | -4.5M | -9.1M | -- |
| Total Capitalization | -738,000 | -3.4M | 1.1M | 5.5M | 866,000 | -- |
| Net Tangible Assets | -19.4M | -14.4M | -7.4M | -4.5M | -9.1M | -- |
| Tangible Book Value | -19.4M | -14.4M | -7.4M | -4.5M | -9.1M | -- |
| Working Capital | -3.3M | -5.7M | 651,000 | 5.1M | 477,000 | -- |
| Invested Capital | -738,000 | -3.4M | 1.1M | 5.5M | 866,000 | -- |
| Total Debt | 19.0M | 11.4M | 9.0M | 10.6M | 10.7M | -- |
| Net Debt | 18.1M | 10.4M | 3.8M | 3.9M | 10.0M | -- |
| Share Issued | 2.6M | 2.6M | 2.6M | 2.0M | 650,706 | -- |
| Ordinary Shares Number | 2.6M | 2.6M | 2.6M | 2.0M | 650,706 | -- |
| Capital Lease Obligations | 305,000 | 413,000 | 521,000 | 621,000 | 721,000 | -- |
| Current Capital Lease Obligation | 305,000 | 413,000 | 441,000 | 428,000 | 416,000 | -- |
| Dueto Related Parties Current | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Interest Payable | 514,000 | 294,000 | 163,000 | -- | -- | -- |
| Leases | -- | -- | -- | 171,000 | -- | -- |
| Machinery Furniture Equipment | -- | -- | -- | 373,000 | -- | -- |
| Other Properties | 3.1M | 3.1M | 3.1M | 3.1M | 3.2M | -- |
| Properties | -- | -- | -- | 0.00 | -- | -- |
| Restricted Cash | 1.0M | 745,000 | 0.00 | 555,000 | 8.0M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.4M | -5.9M | -2.8M | -8.1M | -10.4M | -- |
| Cash Flow From Continuing Operating Activities | -7.4M | -5.9M | -2.8M | -8.1M | -10.4M | -- |
| Depreciation And Amortization | 111,000 | 102,000 | 99,000 | 97,000 | 96,000 | -- |
| Depreciation Amortization Depletion | 111,000 | 102,000 | 99,000 | 97,000 | 96,000 | -- |
| Stock Based Compensation | 44,000 | 65,000 | 326,000 | 57,000 | -13,000 | -- |
| Change In Working Capital | -2.6M | 908,000 | 2.3M | -5.5M | -3.5M | -- |
| Change In Payables And Accrued Expense | -2.0M | 2.6M | 1.7M | -5.3M | -3.0M | -- |
| Change In Payable | -1.4M | 489,000 | 1.1M | -572,000 | -5.3M | -- |
| Change In Other Current Assets | -366,000 | -1.8M | 296,000 | 791,000 | -768,000 | -- |
| Change In Other Current Liabilities | -- | -- | -- | -- | -112,000 | -119,000 |
| Other Non Cash Items | 112,000 | 23,000 | 45,000 | -428,000 | 15,000 | -- |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Purchase Of Investment | -- | -- | 0.00 | -- | -- | -- |
| Net Investment Purchase And Sale | -- | -- | 0.00 | 0.00 | 0.00 | 2.0M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Issuance Of Debt | 7.8M | -- | -- | 0.00 | 10.0M | -- |
| Repayment Of Debt | 0.00 | -- | -- | -- | -- | -- |
| Net Issuance Payments Of Debt | 7.8M | -- | -- | 0.00 | 10.0M | -- |
| Issuance Of Capital Stock | -1,000 | 1,000 | 828,000 | 6.6M | 0.00 | -- |
| Net Common Stock Issuance | -1,000 | 1,000 | 828,000 | 6.6M | 0.00 | -- |
| Financing Cash Flow | 7.8M | 2.5M | 829,000 | 6.8M | 10.0M | -- |
| Cash Flow From Continuing Financing Activities | 7.8M | 2.5M | 829,000 | 6.8M | 10.0M | -- |
| Effect Of Exchange Rate Changes | -- | -- | 2,000 | 0.00 | 0.00 | -1,000 |
| Changes In Cash | 339,000 | -3.4M | -2.0M | -1.3M | -368,000 | -- |
| Beginning Cash Position | 1.3M | 4.7M | 6.7M | 8.0M | 8.3M | -- |
| End Cash Position | 1.6M | 1.3M | 4.7M | 6.7M | 8.0M | -- |
| Free Cash Flow | -7.4M | -5.9M | -2.8M | -8.1M | -10.4M | -- |
| Change In Account Payable | -1.4M | 489,000 | 1.1M | -3.1M | -5.3M | -- |
| Change In Accrued Expense | -610,000 | 2.1M | 551,000 | -4.7M | 2.3M | -- |
| Change In Prepaid Assets | -156,000 | 95,000 | 301,000 | -1.3M | 324,000 | -- |
| Common Stock Issuance | -1,000 | 1,000 | 828,000 | 6.6M | 0.00 | -- |
| Depreciation | 111,000 | 102,000 | 99,000 | 97,000 | 96,000 | -- |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Debt Issuance | 7.8M | -- | -- | 0.00 | 10.0M | -- |
| Net Income From Continuing Operations | -5.1M | -7.0M | -5.5M | -1.6M | -7.0M | -- |
| Net Long Term Debt Issuance | 7.7M | -- | -- | 0.00 | 10.0M | -- |
| Net Other Financing Charges | -- | -- | -- | -- | -- | -177,000 |
| Operating Gains Losses | -- | -- | -- | -686,000 | -- | 66,000 |
| Proceeds From Stock Option Exercised | -- | -- | 1,000 | 2,000 | 8,000 | 0.00 |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | -- | -- | -2,000 | -- | 0.00 | 1,000 |